Happy New Year from Medical Technology!

In the first issue of the year, we explore how the field of fertility health is developing due to technology advancements. Within the clinical environment, research and development in women’s health and infertility has historically been underfunded. However, the space is attracting more attention from investors and technology innovators, many of whom are motivated by their personal fertility experiences.

Read more to find out how advancements in three major categories: embryology laboratory, at-home testing and monitoring and artificial intelligence are changing how treatment will be delivered.

We also look back at some of the key trends that defined the medical device industry in 2022 and what we might expect to see in 2023.

Keep reading for the latest and most significant medical device industry news, data and insights from GlobalData journalists and analysts.

Catherine Longworth, Editor

Go to article: Home | Fertility tech in 2023Go to article: In this issueGo to article: ContentsGo to article: Formacoat Company InsightGo to article: FormacoatGo to article: Mimotopes Company Insight Go to article: BriefingGo to article: Industry newsGo to article: The medical industry briefingGo to article: Alleima Company InsightGo to article: AlleimaGo to article: CommentGo to article: The market for assisted reproductive technology is expected to growGo to article: Digital therapeutics will empower remote patient care in 2023Go to article: Benefits and risks of virtual reality medical devices outlined by the FDAGo to article: In DepthGo to article: Fertility tech in 2023: At-home, personalisation and accessibilityGo to article: 2022 Medtech: The shadow of Covid-19 lingers over industryGo to article: 2022 Medtech M&A activity fails to reach the heady heights of 2021Go to article: Healthier carbon emissions: reducing the environmental impact of healthcareGo to article: EventsGo to article: Next Issue